Citation: | Wei Wei, Ming Yingzi. Discussion on varicella-zoster virus infection after solid organ transplantation[J]. ORGAN TRANSPLANTATION, 2018, 9(5): 399-401. doi: 10.3969/j.issn.1674-7445.2018.05.014 |
[1] |
COHEN JI.The varicella-zoster virus genome[J].Curr Top Microbiol Immunol, 2010, 342:1-14.DOI: 10.1007/82_2010_10.
|
[2] |
COHRS RJ, HURLEY MP, GILDEN DH.Array analysis of viral gene transcription during lytic infection of cells in tissue culture with varicella-zoster virus[J].J Virol, 2003, 77(21):11718-11732. doi: 10.1128/JVI.77.21.11718-11732.2003
|
[3] |
SUENAGA T, SATOH T, SOMBOONTHUM P, et al.Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses[J].Proc Natl Acad Sci U S A, 2010, 107(2):866-871.DOI: 10.1073/pnas.0913351107.
|
[4] |
METTENLEITER TC.Budding events in herpesvirus morphogenesis[J].Virus Res, 2004, 106(2):167-180. doi: 10.1016/j.virusres.2004.08.013
|
[5] |
SKRIPULETZ T, PARS K, SCHULTE A, et al.Varicella zoster virus infections in neurological patients:a clinical study[J].BMC Infect Dis, 2018, 18(1):238.DOI: 10.1186/s12879-018-3137-2.
|
[6] |
MARIN M, GÜRIS D, CHAVES SS, et al.Prevention of varicella:recommendations of the Advisory Committee on Immunization Practices (ACIP)[J].MMWR Recomm Rep, 2007, 56(RR-4):1-40. https://www.ncbi.nlm.nih.gov/pubmed/8668119
|
[7] |
GOURISHANKAR S, MCDERMID JC, JHANGRI GS, et al.Herpes zoster infection following solid organ transplantation:incidence, risk factors and outcomes in the current immunosuppressive era[J].Am J Transplant, 2004, 4(1):108-115. doi: 10.1046/j.1600-6143.2003.00287.x
|
[8] |
KIRNAP M, AKDUR A, AYVAZOĞLU SOY HE, et al.Prevalence and outcome of herpes zoster infection in renal transplant recipients[J].Exp Clin Transplant, 2015, 13 (Suppl 1):280-283. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=JJ0225070085
|
[9] |
贺腾辉, 钱叶勇, 范宇, 等.单中心肾移植术后带状疱疹的相关危险因素分析[J].器官移植, 2017, 8(3):215-219.DOI: 10.3969/j.issn.1674-7445.2017.03.008.
HE TH, QIAN YY, FAN Y, et al.Analysis of risk factors of herpes zoster after renal transplantation in a single center[J].Organ Transplant, 2017, 8(3):215-219.DOI: 10.3969/j.issn.1674-7445.2017.03.008.
|
[10] |
PERGAM SA, FORSBERG CW, BOECKH MJ, et al.Herpes zoster incidence in a multicenter cohort of solid organ transplant recipients[J].Transpl Infect Dis, 2011, 13(1):15-23.DOI: 10.1111/j.1399-3062.2010.00547.x.
|
[11] |
MANUEL O, KUMAR D, SINGER LG, et al.Incidence and clinical characteristics of herpes zoster after lung transplantation[J].J Heart Lung Transplant, 2008, 27(1):11-16.DOI: 10.1016/j.healun.2007.09.028.
|
[12] |
ARNESS T, PEDERSEN R, DIERKHISING R, et al.Varicella zoster virus-associated disease in adult kidney transplant recipients:incidence and risk-factor analysis[J].Transpl Infect Dis, 2008, 10(4):260-268. doi: 10.1111/tid.2008.10.issue-4
|
[13] |
ARVIN AM.Humoral and cellular immunity to varicella-zoster virus:an overview[J].J Infect Dis, 2008, 197(Suppl 2):S58-S60.DOI: 10.1086/522123.
|
[14] |
LAUZURICA R, BAYÉS B, FRÍAS C, et al.Disseminated varicella infection in adult renal allograft recipients:role of mycophenolate mofetil[J].Transplant Proc, 2003, 35(5):1758-1759. doi: 10.1016/S0041-1345(03)00684-5
|
[15] |
LEUNG AK, KAO CP, SAUVE RS.Scarring resulting from chickenpox[J].Pediatr Dermatol, 2001, 18(5):378-380. doi: 10.1046/j.1525-1470.2001.01975.x
|
[16] |
ROMMELAERE M, MARÉCHAL C, YOMBI JC, et al.Disseminated varicella zoster virus infection in adult renal transplant recipients:outcome and risk factors[J].Transplant Proc, 2012, 44(9):2814-2817.DOI: 10.1016/j.transproceed.2012.09.090.
|
[17] |
JANTSCH J, SCHMIDT B, BARDUTZKY J, et al.Lethal varicella-zoster virus reactivation without skin lesions following renal transplantation[J].Nephrol Dial Transplant, 2011, 26(1):365-368.DOI: 10.1093/ndt/gfq542.
|
[18] |
HOVENS MM, VAESSEN N, SIJPKENS YW, et al.Unusual presentation of central nervous system manifestations of varicella zoster virus vasculopathy in renal transplant recipients[J].Transpl Infect Dis, 2007, 9(3):237-240. doi: 10.1111/tid.2007.9.issue-3
|
[19] |
MIROUSE A, VIGNON P, PIRON P, et al.Severe varicella-zoster virus pneumonia:a multicenter cohort study[J].Crit Care, 2017, 21(1):137.DOI: 10.1186/s13054-017-1731-0.
|
[20] |
GILDEN D, COHRS RJ, MAHALINGAM R, et al.Varicella zoster virus vasculopathies:diverse clinical manifestations, laboratory features, pathogenesis, and treatment[J].Lancet Neurol, 2009, 8(8):731-740.DOI: 10.1016/S1474-4422(09)70134-6.
|
[21] |
PAPANICOLAOU GA, MEYERS BR, FUCHS WS, et al.Infectious ocular complications in orthotopic liver transplant patients[J].Clin Infect Dis, 1997, 24(6):1172-1177. doi: 10.1086/cid.1997.24.issue-6
|
[22] |
SAITOH H, TAKAHASHI N, NANJO H, et al.Varicella-zoster virus-associated fulminant hepatitis following allogeneic hematopoietic stem cell transplantation for multiple myeloma[J].Intern Med, 2013, 52(15):1727-1730. doi: 10.2169/internalmedicine.52.0118
|
[23] |
CHHABRA P, RANJAN P, BHASIN DK.Simultaneous occurrence of varicella zoster virus-induced pancreatitis and hepatitis in a renal transplant recipient:a case report and review of literature[J].Perm J, 2017, 21.DOI: 10.7812/TPP/16-083.
|
[24] |
ZUCKERMAN RA, LIMAYE AP.Varicella zoster virus (VZV) and herpes simplex virus (HSV) in solid organ transplant patients[J].Am J Transplant, 2013, 13 (Suppl 3):55-66.DOI: 10.1111/ajt.12003.
|
[25] |
LEGOFF J, PÉRÉ H, BÉLEC L.Diagnosis of genital herpes simplex virus infection in the clinical laboratory[J].Virol J, 2014, 11:83.DOI: 10.1186/1743-422X-11-83.
|
[26] |
CORREA SIERRA CB, KOURÍ CARDELLÁ V, PÉREZ SANTOS L, et al.Herpesviruses excretion in saliva of pediatric transplant recipients[J].Transpl Infect Dis, 2017, 19(6).DOI: 10.1111/tid.12771.
|
[27] |
MARTIN-GANDUL C, STAMPF S, HÉQUET D, et al.Preventive strategies against cytomegalovirus and incidence of α-herpesvirus infections in solid organ transplant recipients:a nationwide cohort study[J].Am J Transplant, 2017, 17(7):1813-1822.DOI: 10.1111/ajt.14192.
|